Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
LadRx Corp - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
LADX
Over the counter
2835
https://www.ladrxcorp.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for LadRx Corp
LadRx Issues 2024 Update to Shareholders
- Jan 9th, 2024 1:00 pm
LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation
- Jun 22nd, 2023 11:30 am
LadRx Announces Reverse Stock Split Effective as of May 17, 2023
- May 18th, 2023 12:00 pm
LadRx Announces Reverse Stock Split
- May 10th, 2023 12:00 pm
Scroll